Balance Sheet
Cash Flow Statement
Beginning Cash BalanceBeginning Cash BalanceCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Cash from Investing Activities (2019 - 2025)

Burning Rock Biotech has reported Cash from Investing Activities over the past 7 years, most recently at -$46000.0 for Q4 2025.

  • For Q4 2025, Cash from Investing Activities rose 58.56% year-over-year to -$46000.0; the TTM value through Dec 2025 reached -$828000.0, up 15.94%, while the annual FY2025 figure was -$628000.0, 3.97% down from the prior year.
  • Cash from Investing Activities for Q4 2025 was -$46000.0 at Burning Rock Biotech, up from -$386000.0 in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $44.0 million in Q1 2021 and troughed at -$11.2 million in Q3 2021.
  • A 5-year average of $385150.0 and a median of -$358000.0 in 2024 define the central range for Cash from Investing Activities.
  • Biggest five-year swings in Cash from Investing Activities: soared 8600.12% in 2021 and later tumbled 496.77% in 2025.
  • Year by year, Cash from Investing Activities stood at -$10.5 million in 2021, then soared by 93.05% to -$730000.0 in 2022, then soared by 93.7% to -$46000.0 in 2023, then crashed by 141.3% to -$111000.0 in 2024, then soared by 58.56% to -$46000.0 in 2025.
  • Business Quant data shows Cash from Investing Activities for BNR at -$46000.0 in Q4 2025, -$386000.0 in Q3 2025, and -$185000.0 in Q2 2025.